Put It on the Board

Create PDF

TSO 500 is a research-use-only comprehensive pan-cancer assay designed to identify 523 known and emerging tumor biomarkers. Based on the content of TSO 500, Illumina will be adding an in vitro diagnostic test to the TruSight Oncology product family. This comprehensive tumor profiling assay will have similar chemistry and analytics to TSO 500.

CliniSys acquires Horizon Lab Systems

CliniSys has acquired Horizon Lab Systems and will combine with Sunquest Information Systems, under the brand name CliniSys. Roper Technologies, CliniSys’ parent company, owns Sunquest.

This acquisition and Sunquest combination create one of the world’s largest organizations dedicated to diagnostics and laboratory informatics, CliniSys said in a Jan. 18 news release.

CliniSys describes its vision as going “beyond the walls of the clinical laboratory to embrace a new wave of digital diagnostics and laboratories across the continuum of care and community to improve public health.” Horizon is critical to this vision, it says, with its advanced cloud-based laboratory solutions and expertise in environmental, water quality testing, public health, toxicology, and agriculture laboratory solutions.

CliniSys is headquartered in Chertsey, England and Tucson, Ariz.